These are known as HeLa cells because they were originally isolated from a woman named Henrietta Lacks. She went to Johns Hopkins Medical Center in 1951 and was diagnosed with cervical cancer. She ...

This could account for some reproducibility problems in cell line research, according to the authors of a comprehensive analysis of HeLa variants. After a year teaching an algorithm to differentiate ...

It further asserts that Ultragenyx has "made a fortune by using Mrs Lacks's stolen cells as a factory to make its 'proprietary' gene therapy products." The case centres around the use of HeLa ...

Novartis and Viatris have become the latest pharma companies to be named in lawsuits claiming that they profited from the unlawful use of HeLa cells derived from cells taken from a cancer patient ...